Business Context and Reporting Period
This Form 8-K is a current report filed by iBio, Inc. on January 9, 2020. The filing addresses corporate governance matters specifically related to the scheduling of the Company's 2019 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on shareholder meeting logistics and does not contain financial performance data.
Material Changes
The primary material change reported is the rescheduling of the 2019 Annual Meeting of Stockholders. The Board of Directors established the meeting date as Monday, February 10, 2020. This date represents a delay of more than 30 days from the anniversary of the 2018 Annual Meeting, triggering specific disclosure requirements under Rule 14a-5(f) of the Exchange Act.
Guidance, Outlook, and Corporate Actions
- Meeting Date: The 2019 Annual Meeting is scheduled for February 10, 2020.
- Record Date: Stockholders of record as of the close of business on January 13, 2020, are entitled to vote.
- Proposal Deadlines: Due to the date change, a new deadline for stockholder proposals under Rule 14a-8 and director nominations under the Company's Bylaws has been set. Proposals must be received by the Company's Secretary by the close of business on January 15, 2020.
- Location and Time: Specific time and location details are reserved for the Company's proxy statement.
Key Facts for Investor Verification
- Verify the record date of January 13, 2020, to confirm voting eligibility.
- Note the strict January 15, 2020, deadline for submitting shareholder proposals or director nominations.
- Monitor the upcoming proxy statement for the specific time and location of the February 10, 2020, meeting.
- Confirm that no financial results or operational updates were included in this specific filing.